References
Key articles
World Health Organization. Clinical management and infection prevention and control for mpox: living guideline, May 2025. Jun 2025 [internet publication].Full text
Centers for Disease Control and Prevention. Clinical overview of mpox. Apr 2025 [internet publication].Full text
World Health Organization. Surveillance, case investigation and contact tracing for mpox: interim guidance, 27 November 2024. Dec 2024 [internet publication].Full text
Centers for Disease Control and Prevention. Clinical treatment of mpox. Aug 2025 [internet publication].Full text
World Health Organization. Diagnostic testing for the monkeypox virus (MPXV): interim guidance. May 2024 [internet publication].Full text
Centers for Disease Control and Prevention. Clinical considerations for pain management. Sep 2024 [internet publication].Full text
Reference articles
1. World Health Organization. Clinical management and infection prevention and control for mpox: living guideline, May 2025. Jun 2025 [internet publication].Full text
2. Health and Safety Executive, Advisory Committee on Dangerous Pathogens. The approved list of biological agents. July 2021 [internet publication].Full text
3. World Health Organization. WHO recommends new name for monkeypox disease. Nov 2022 [internet publication].Full text
4. Bunge EM, Hoet B, Chen L, et al. The changing epidemiology of human monkeypox – a potential threat? A systematic review. PLoS Negl Trop Dis. 2022 Feb;16(2):e0010141.Full text Abstract
5. Beer EM, Rao VB. A systematic review of the epidemiology of human monkeypox outbreaks and implications for outbreak strategy. PLoS Negl Trop Dis. 2019 Oct;13(10):e0007791.Full text Abstract
6. Nguyen PY, Ajisegiri WS, Costantino V, et al. Reemergence of human monkeypox and declining population immunity in the context of urbanization, Nigeria, 2017-2020. Emerg Infect Dis. 2021 Apr;27(4):1007-14.Full text Abstract
7. World Health Organization. Epidemiology of human monkeypox (mpox) - worldwide, 2018-2021. Jan 2023 [internet publication].Full text
8. Besombes C, Mbrenga F, Schaeffer L, et al. National monkeypox surveillance, Central African Republic, 2001-2021. Emerg Infect Dis. 2022 Nov 3;28(12). Abstract
9. McCollum AM, Shelus V, Hill A, et al. Epidemiology of human mpox: worldwide, 2018-2021. MMWR Morb Mortal Wkly Rep. 2023 Jan 20;72(3):68-72.Full text Abstract
10. Besombes C, Mbrenga F, Malaka C, et al. Investigation of a mpox outbreak in Central African Republic, 2021-2022. One Health. 2023 Jun;16:100523.Full text Abstract
11. World Health Organization. Mpox: fact sheet. Aug 2024 [internet publication].Full text
12. Centers for Disease Control and Prevention. Mpox in the United States and around the world: current situation. Aug 2025 [internet publication].Full text
13. World Health Organization. Global mpox trends. Aug 2025 [internet publication].Full text
14. León-Figueroa DA, Barboza JJ, Garcia-Vasquez EA, et al. Epidemiological situation of monkeypox transmission by possible sexual contact: a systematic review. Trop Med Infect Dis. 2022 Sep 27;7(10):267.Full text Abstract
15. Kumar R, Singh S, Singh SK. A systematic review of 5110 cases of monkeypox: what has changed between 1970 and 2022? Cureus. 2022 Oct;14(10):e30841.Full text Abstract
16. Liu Q, Fu L, Wang B, et al. Clinical characteristics of human mpox (monkeypox) in 2022: a systematic review and meta-analysis. Pathogens. 2023 Jan 15;12(1):146.Full text Abstract
17. Grothe JH, Cornely OA, Salmanton-García J, et al. Monkeypox in children and adult women in Europe: results from a flash VACCELERATE pilot survey. Enferm Infecc Microbiol Clin. 2023 May;41(5):309-11.Full text Abstract
18. Vallejo-Plaza A, Rodríguez-Cabrera F, Hernando Sebastián V, et al. Mpox (formerly monkeypox) in women: epidemiological features and clinical characteristics of mpox cases in Spain, April to November 2022. Euro Surveill. 2022 Dec;27(48):2200867.Full text Abstract
19. Gaeta F, De Caro F, Franci G, et al. Monkeypox infection 2022: an updated narrative review focusing on the neonatal and pediatric population. Children (Basel). 2022 Nov 26;9(12):1832.Full text Abstract
20. Oakley LP, Hufstetler K, O'Shea J, et al. Mpox cases among cisgender women and pregnant persons: United States, May 11 - November 7, 2022. MMWR Morb Mortal Wkly Rep. 2023 Jan 6;72(1):9-14.Full text Abstract
21. Ogoina D, Dalhat MM, Denue BA, et al. Clinical characteristics and predictors of human mpox outcome during the 2022 outbreak in Nigeria: a cohort study. Lancet Infect Dis. 2023 Aug 22:S1473-3099(23)00427-9.Full text Abstract
22. Blackburn D, Roth NM, Gold JAW, et al. Epidemiologic and clinical features of mpox in transgender and gender-diverse adults: United States, May - November 2022. MMWR Morb Mortal Wkly Rep. 2022 Dec 30;71(5152):1605-9.Full text Abstract
23. Wick JM, Pelliccione A, Lee-Rodriguez C, et al. An atypical presentation of mpox transmitted between transgender men through oral sex. Sex Transm Dis. 2023 Oct 1;50(10):685-6.Full text Abstract
24. Kota KK, Hong J, Zelaya C, et al. Racial and ethnic disparities in Mpox cases and vaccination among adult males - United States, May-December 2022. MMWR Morb Mortal Wkly Rep. 2023 Apr 14;72(15):398-403.Full text Abstract
25. World Health Organization. WHO rapid risk assessment - mpox, global v.4. Jul 2025 [internet publication].Full text
26. World Health Organization. Fourth meeting of the International Health Regulations (2005) Emergency Committee regarding the upsurge of mpox 2024. Jul 2025 [internet publication].Full text
27. Ndembi N, Folayan MO, Komakech A, et al. Evolving epidemiology of mpox in Africa in 2024. N Engl J Med. 2025 Feb 13;392(7):666-76.Full text Abstract
28. World Health Organization. Disease outbreak news: mpox - Democratic Republic of the Congo. Jun 2024 [internet publication].Full text
29. World Health Organization. Disease outbreak news: mpox - African region. Aug 2024 [internet publication].Full text
30. Brosius I, Vakaniaki EH, Mukari G, et al. Epidemiological and clinical features of mpox during the clade Ib outbreak in South Kivu, Democratic Republic of the Congo: a prospective cohort study. Lancet. 2025 Feb 15;405(10478):547-59. Abstract
31. Vakaniaki EH, Kacita C, Kinganda-Lusamaki E, et al. Sustained human outbreak of a new MPXV clade I lineage in eastern Democratic Republic of the Congo. Nat Med. 2024 Oct;30(10):2791-5.Full text Abstract
32. Nzoyikorera N, Nduwimana C, Schuele L, et al. Monkeypox clade Ib virus introduction into Burundi: first findings, July to mid-August 2024. Euro Surveill. 2024 Oct;29(42):2400666.Full text Abstract
33. Li P, Li J, Ayada I, et al. Clinical features, antiviral treatment and patient outcomes: a systematic review and comparative analysis of the previous and the 2022 mpox outbreaks. J Infect Dis. 2023 Aug 16;228(4):391-401.Full text Abstract
34. Hoxha A, Kerr SM, Laurenson-Schafer H, et al. Mpox in children and adolescents during multicountry outbreak, 2022-2023. Emerg Infect Dis. 2023 Oct;29(10):2125-9.Full text Abstract
35. Centers for Disease Control and Prevention. Clinical considerations for mpox in children and adolescents in the U.S. Aug 2025 [internet publication].Full text
36. Centers for Disease Control and Prevention. Clinical considerations for mpox in immunocompromised people. Aug 2025 [internet publication].Full text
37. O'Shea J, Filardo TD, Morris SB, et al. Interim guidance for prevention and treatment of monkeypox in persons with HIV infection: United States, August 2022. MMWR Morb Mortal Wkly Rep. 2022 Aug 12;71(32):1023-8.Full text Abstract
38. Thornhill JP, Palich R, Ghosn J, et al. Human monkeypox virus infection in women and non-binary individuals during the 2022 outbreaks: a global case series. Lancet. 2022 Dec 3;400(10367):1953-65.Full text Abstract
39. UK Health Security Agency. Monkeypox case in England. December 2018 [internet publication].Full text
40. UK Health Security Agency. Monkeypox case confirmed in England. Dec 2019 [internet publication].Full text
41. World Health Organization. Disease outbreak news: monkeypox - United Kingdom of Great Britain and Northern Ireland. Jul 2021 [internet publication].Full text
42. World Health Organization. Disease outbreak news: monkeypox - United Kingdom of Great Britain and Northern Ireland. May 2022 [internet publication].Full text
43. Centers for Disease Control and Prevention. Imported monkeypox case reported in Maryland. Nov 2021 [internet publication].Full text
44. Centers for Disease Control and Prevention. CDC and Texas confirm monkeypox in U.S. traveler. Jul 2021 [internet publication].Full text
45. Rao AK, Schulte J, Chen TH, et al. Monkeypox in a traveler returning from Nigeria – Dallas, Texas, July 2021. MMWR Morb Mortal Wkly Rep. 2022 Apr 8;71(14):509-16.Full text Abstract
46. World Health Organization. Disease outbreak news: monkeypox - Singapore. May 2019 [internet publication].Full text
47. Erez N, Achdout H, Milrot E, et al. Diagnosis of imported monkeypox, Israel, 2018. Emerg Infect Dis. 2019 May;25(5):980-3.Full text Abstract
48. Huhn GD, Bauer AM, Yorita K, et al. Clinical characteristics of human monkeypox, and risk factors for severe disease. Clin Infect Dis. 2005 Dec 15;41(12):1742-51.Full text Abstract
49. World Health Organization. Monkeypox: experts give virus variants new names. Aug 2022 [internet publication].Full text
50. Happi C, Adetifa I, Mbala P, et al. Urgent need for a non-discriminatory and non-stigmatizing nomenclature for monkeypox virus. PLoS Biol. 2022 Aug 23;20(8):e3001769.Full text Abstract
51. World Health Organization. Risk evaluation of clade Ia monkeypox virus: review of evidence. Jan 2025 [internet publication].Full text
52. World Health Organization. Risk evaluation of clade Ib monkeypox virus: review of evidence. Jan 2025 [internet publication].Full text
53. Centers for Disease Control and Prevention. Clinical overview of mpox. Apr 2025 [internet publication].Full text
54. Luna N, Ramírez AL, Muñoz M, et al. Phylogenomic analysis of the monkeypox virus (MPXV) 2022 outbreak: emergence of a novel viral lineage? Travel Med Infect Dis. 2022 Jul 13;49:102402. Abstract
55. UK Health Security Agency. Monkeypox outbreak: technical briefings. Dec 2024 [internet publication].Full text
56. Woolley SD, Lester R, Devine K, et al. Clade IIb A.3 monkeypox virus: an imported lineage during a large global outbreak. Lancet Infect Dis. 2023 Apr;23(4):405.Full text Abstract
57. Sukhdeo S, Mishra S, Walmsley S. Human monkeypox: a comparison of the characteristics of the new epidemic to the endemic disease. BMC Infect Dis. 2022 Dec 12;22(1):928.Full text Abstract
58. Hatami H, Jamshidi P, Arbabi M, et al. Demographic, epidemiologic, and clinical characteristics of human Monkeypox disease pre- and post-2022 Outbreaks: a systematic review and meta-analysis. Biomedicines. 2023 Mar 20;11(3):957.Full text Abstract
59. Haddad N. The presumed receptivity and susceptibility to monkeypox of European animal species. Infect Dis Now. 2022 Aug;52(5):294-8.Full text Abstract
60. Pinto P, Costa MA, Gonçalves MFM, et al. Mpox person-to-person transmission-where have we got so far? a systematic review. Viruses. 2023 Apr 28;15(5):1074.Full text Abstract
61. Vakaniaki EH, Kuispond NS, Hirata Y, et al. Three cases of vertical transmission of clade Ib mpox virus. N Engl J Med. 2025 Jun 19;392(23):2385-7.Full text
62. UK Health Security Agency. Mpox routes of transmission. Jan 2025 [internet publication].Full text
63. Kibungu EM, Vakaniaki EH, Kinganda-Lusamaki E, et al. Clade I-associated mpox cases associated with sexual contact, the Democratic Republic of the Congo. Emerg Infect Dis. 2024 Jan;30(1):172-6.Full text Abstract
64. Vanhamel J, Laisnez V, Liesenborghs L, et al. Understanding sexual transmission dynamics and transmission contexts of monkeypox virus: a mixed-methods study of the early outbreak in Belgium (May-June 2022). Sex Transm Infect. 2023 Aug;99(5):330-6.Full text Abstract
65. Karan A, Styczynski AR, Huang C, et al. Human monkeypox without viral prodrome or sexual exposure, California, USA, 2022. Emerg Infect Dis. 2022 Aug 16;28(10):2121-3.Full text Abstract
66. Hernandez LE, Jadoo A, Kirsner RS. Human monkeypox virus infection in an immunocompromised man: trial with tecovirimat. Lancet. 2022 Sep 10;400(10355):e8.Full text Abstract
67. Saunders KE, Van Horn AN, Medlin HK, et al. Monkeypox in a young infant: Florida, 2022. MMWR Morb Mortal Wkly Rep. 2022 Sep 23;71(38):1220-1.Full text Abstract
68. Aguilera-Alonso D, Alonso-Cadenas JA, Roguera-Sopena M, et al. Monkeypox virus infections in children in Spain during the first months of the 2022 outbreak. Lancet Child Adolesc Health. 2022 Nov;6(11):e22-3.Full text Abstract
69. Reda A, Abdelaal A, Brakat AM, et al. Monkeypox viral detection in semen specimens of confirmed cases: a systematic review and meta-analysis. J Med Virol. 2022 Oct 22:e28250.Full text Abstract
70. Palich R, Burrel S, Monsel G, et al. Viral loads in clinical samples of men with monkeypox virus infection: a French case series. Lancet Infect Dis. 2023 Jan;23(1):74-80.Full text Abstract
71. Lim CK, McKenzie C, Deerain J, et al. Correlation between monkeypox viral load and infectious virus in clinical specimens. J Clin Virol. 2023 Apr;161:105421.Full text Abstract
72. Rani I, Goyal A, Shamim MA, et al. Prevalence of mpox viral DNA in cutaneous specimens of monkeypox-infected patients: a systematic review and meta-analysis. Front Cell Infect Microbiol. 2023;13:1179885.Full text Abstract
73. World Health Organization. Multi-country monkeypox outbreak: situation update. Jun 2022 [internet publication].Full text
74. Sah R, Abdelaal A, Reda A, et al. Monkeypox and its possible sexual transmission: where are we now with its evidence? Pathogens. 2022 Aug 17;11(8):924.Full text Abstract
75. Barboza JJ, León-Figueroa DA, Saldaña-Cumpa HM, et al. Virus identification for monkeypox in human seminal fluid samples: a systematic review. Trop Med Infect Dis. 2023 Mar 14;8(3):173.Full text Abstract
76. Peiró-Mestres A, Fuertes I, Camprubí-Ferrer D, et al. Frequent detection of monkeypox virus DNA in saliva, semen, and other clinical samples from 12 patients, Barcelona, Spain, May to June 2022. Euro Surveill. 2022 Jul;27(28):2200503.Full text Abstract
77. Suñer C, Ubals M, Tarín-Vicente EJ, et al. Viral dynamics in patients with monkeypox infection: a prospective cohort study in Spain. Lancet Infect Dis. 2023 Apr;23(4):445-53.Full text Abstract
78. European Centre for Disease Prevention and Control. Monkeypox multi-country outbreak: second update. Oct 2022 [internet publication].Full text
79. World Health Organization. Surveillance, case investigation and contact tracing for mpox: interim guidance, 27 November 2024. Dec 2024 [internet publication].Full text
80. Beeson A, Styczynski A, Hutson CL, et al. Mpox respiratory transmission: the state of the evidence. Lancet Microbe. 2023 Apr;4(4):e277-83.Full text Abstract
81. Leong FY, Ge Z, Loo LH, et al. Aerosol transmission risk of mpox relative to COVID-19 and smallpox. Lancet Microbe. 2025 Feb 6:101082.Full text Abstract
82. Siedner MJ, Trinidad J, Berto CG, et al. Mpox in young woman with no epidemiologic risk factors, Massachusetts, USA. Emerg Infect Dis. 2023 Jan 25;29(4).Full text Abstract
83. Nörz D, Pfefferle S, Brehm TT, et al. Evidence of surface contamination in hospital rooms occupied by patients infected with monkeypox, Germany, June 2022. Euro Surveill. 2022 Jun;27(26).Full text Abstract
84. Atkinson B, Burton C, Pottage T, et al. Infection-competent monkeypox virus contamination identified in domestic settings following an imported case of monkeypox into the UK. Environ Microbiol. 2022 Oct;24(10):4561-9.Full text Abstract
85. Morgan CN, Whitehill F, Doty JB, et al. Environmental persistence of monkeypox virus on surfaces in household of person with travel-associated infection, Dallas, Texas, USA, 2021. Emerg Infect Dis. 2022 Aug 11;28(10):1982-9.Full text Abstract
86. Muller MP, Mishra S, McGeer A, et al. Environmental testing of surfaces in the room of a patient with mpox. Clin Infect Dis. 2023 Jan 6;76(1):179-81. Abstract
87. Pfeiffer JA, Collingwood A, Rider LE, et al. High-contact object and surface contamination in a household of persons with monkeypox virus infection: Utah, June 2022. MMWR Morb Mortal Wkly Rep. 2022 Aug 26;71(34):1092-4.Full text Abstract
88. Atkinson B, Gould S, Spencer A, et al. Monkeypox virus contamination in an office-based workplace environment. J Hosp Infect. 2022 Dec;130:141-3.Full text Abstract
89. Gould S, Atkinson B, Onianwa O, et al. Air and surface sampling for monkeypox virus in a UK hospital: an observational study. Lancet Microbe. 2022 Dec;3(12):e904-11.Full text Abstract
90. Atkinson B, Gould S, Nicholls I, et al. Air and surface sampling for clade Ib monkeypox virus in United Kingdom hospitals, 2024 to 2025. Euro Surveill. 2025 May;30(19):2500288.Full text Abstract
91. Banete A, Hurst JR, Yim W, et al. Stability of monkeypox virus on commonly contacted surfaces in clinical settings. Open Forum Infect Dis. 2025 May;12(5):ofaf225.Full text Abstract
92. Ramnarayan P, Mitting R, Whittaker E, et al. Neonatal monkeypox virus infection. N Engl J Med. 2022 Oct 27;387(17):1618-20.Full text Abstract
93. Van de Perre P, Molès JP, Rollins N. Is monkeypox virus transmissible by breastfeeding? Pediatr Allergy Immunol. 2022 Oct;33(10):e13861.Full text Abstract
94. Alonso-Cadenas JA, Andina-Martínez D, García-García CJ, et al. Monkeypox disease in a breastfeeding infant. Pediatr Dermatol. 2023 Jan;40(1):214-5. Abstract
95. Satapathy P, Mohanty P, Manna S, et al. Potentially asymptomatic infection of monkeypox virus: a systematic review and meta-analysis. Vaccines (Basel). 2022 Dec 6;10(12):2083.Full text Abstract
96. UK Health Security Agency. Mpox asymptomatic and pre-symptomatic transmission. Jan 2025 [internet publication].Full text
97. Diaz Brochero C, Nocua-Báez LC, Cortes JA, et al. Decoding mpox: a systematic review and meta-analysis of the transmission and severity parameters of the 2022-2023 global outbreak. BMJ Glob Health. 2025 Jan 31;10(1):e016906.Full text Abstract
98. Ward T, Christie R, Paton RS, et al. Transmission dynamics of monkeypox in the United Kingdom: contact tracing study. BMJ. 2022 Nov 2;379:e073153.Full text Abstract
99. Brosius I, Van Dijck C, Coppens J, et al. Presymptomatic viral shedding in high-risk mpox contacts: a prospective cohort study. J Med Virol. 2023 May;95(5):e28769.Full text Abstract
100. Kubo T, Hayakawa K, Akiyama Y, et al. A case of confirmed pre-symptomatic transmission of mpox. J Infect Chemother. 2023 Oct;29(10):1008-9. Abstract
101. Fenner F, Henderson DA, Arita I, et al. Chapter 29: Human monkeypox and other poxvirus infections of man. In: Smallpox and its eradication. Geneva: World Health Organization; 1988.Full text
102. Reda A, El-Qushayri AE, Shah J. Asymptomatic monkeypox infection: a call for greater control of infection and transmission. Lancet Microbe. 2023 Jan;4(1):e15-6.Full text Abstract
103. Ferré VM, Bachelard A, Zaidi M, et al. Detection of monkeypox virus in anorectal swabs from asymptomatic men who have sex with men in a sexually transmitted infection screening program in Paris, France. Ann Intern Med. 2022 Oct;175(10):1491-2.Full text Abstract
104. Moschese D, Pozza G, Mileto D, et al. Isolation of viable monkeypox virus from anal and urethral swabs, Italy, May to July 2022. Euro Surveill. 2022 Sep;27(36).Full text Abstract
105. Cassir N, Cardona F, Tissot-Dupont H, et al. Observational cohort study of evolving epidemiologic, clinical, and virologic features of monkeypox in Southern France. Emerg Infect Dis. 2022 Oct 14;28(12).Full text Abstract
106. Accordini S, Cordioli M, Pomari E, et al. People with asymptomatic or unrecognised infection potentially contribute to monkeypox virus transmission. Lancet Microbe. 2023 Apr;4(4):e209.Full text
107. Rossotti R, Calzavara D, Cernuschi M, et al. Detection of asymptomatic mpox carriers among high-ri men who have sex with men: a prospective analysis. Pathogens. 2023 Jun 3;12(6):798.Full text Abstract
108. Pitt-Kendall R, Foster C, Rayment M, et al. Retrospective testing for mpox virus in routine STI screens from men who have sex with men in England, August-October 2022. Sex Transm Infect. 2023 Aug 3:sextrans-2023-055841. Abstract
109. Hampel B, Farnham A, Lamothe-Molina PJ, et al. Low prevalence of asymptomatic mpox in populations at high risk. Lancet Microbe. 2023 Nov;4(11):e856.Full text
110. Grabmeier-Pfistershammer K, Skorepa C, Breuer M, et al. No evidence of asymptomatic monkeypox infection in a highly sexually active MSM population in Austria. HIV Med. 2023 Aug 31.Full text Abstract
111. UK Health Security Agency. Mpox incubation and infectious periods. Jan 2025 [internet publication].Full text
112. Thornhill JP, Barkati S, Walmsley S, et al. Monkeypox virus infection in humans across 16 countries: April–June 2022. N Engl J Med. 2022 Aug 25;387(8):679-91.Full text Abstract
113. Okoli GN, Van Caeseele P, Askin N, et al. Comparative evaluation of the clinical presentation and epidemiology of the 2022 and previous mpox outbreaks: a rapid review and meta-analysis. Infect Dis (Lond). 2023 Jul;55(7):490-508. Abstract
114. Kwok KO, Wei WI, Tang A, et al. Estimation of local transmissibility in the early phase of monkeypox epidemic in 2022. Clin Microbiol Infect. 2022 Dec;28(12):1653.e1-3.Full text Abstract
115. Branda F, Pierini M, Mazzoli S. Monkeypox: early estimation of basic reproduction number R0 in Europe. J Med Virol. 2022 Nov 1:e28270.Full text Abstract
116. Nolen LD, Osadebe L, Katomba J, et al. Introduction of monkeypox into a community and household: risk factors and zoonotic reservoirs in the Democratic Republic of the Congo. Am J Trop Med Hyg. 2015 Aug;93(2):410-5.Full text Abstract
117. Thomas ES, Madewell ZJ, Still WL, et al. Notes from the field: transmission of mpox to nonsexual close contacts - two U.S. jurisdictions, May 1-July 31, 2022. MMWR Morb Mortal Wkly Rep. 2023 Dec 15;72(50):1351-2.Full text Abstract
118. Delea KC, Chen TH, Lavilla K, et al. Contact tracing for mpox clade II cases associated with air travel - United States, July 2021-August 2022. MMWR Morb Mortal Wkly Rep. 2024 Sep 5;73(35):758-62.Full text Abstract
119. Kaler J, Hussain A, Flores G, et al. Monkeypox: a comprehensive review of transmission, pathogenesis, and manifestation. Cureus. 2022 Jul;14(7):e26531.Full text Abstract
120. Lum FM, Torres-Ruesta A, Tay MZ, et al. Monkeypox: disease epidemiology, host immunity and clinical interventions. Nat Rev Immunol. 2022 Oct;22(10):597-613.Full text Abstract
121. Al-Musa A, Chou J, LaBere B. The resurgence of a neglected orthopoxvirus: Immunologic and clinical aspects of monkeypox virus infections over the past six decades. Clin Immunol. 2022 Oct;243:109108.Full text Abstract
122. Ugwu CLJ, Bragazzi NL, Wu J, et al. Risk factors associated with human Mpox infection: a systematic review and meta-analysis. BMJ Glob Health. 2025 Feb 3;10(2):e016937.Full text Abstract
123. Marshall KE, Barton M, Nichols J, et al. Health care personnel exposures to subsequently laboratory-confirmed monkeypox patients: Colorado, 2022. MMWR Morb Mortal Wkly Rep. 2022 Sep 23;71(38):1216-9.Full text Abstract
124. Safir A, Safir M, Henig O, et al. Nosocomial transmission of MPOX virus to health care workers: an emerging occupational hazard - a case report and review of the literature. Am J Infect Control. 2023 Sep;51(9):1072-6.Full text Abstract
125. Szkiela M, Wiszniewska M, Lipińska-Ojrzanowska A. Monkeypox (Mpox) and occupational exposure. Int J Environ Res Public Health. 2023 Mar 14;20(6):5087.Full text Abstract
126. Barger A, Duncan J, Traore D, et al. Lack of mpox transmission in a long-term care facility despite widespread exposure: Kentucky, 2023. Am J Infect Control. 2025 Jan 26 [Epub ahead of print]. Abstract
127. Ladhani SN, Aiano F, Edwards DS, et al. Very low risk of monkeypox among staff and students after exposure to a confirmed case in educational settings, England, May to July 2022. Euro Surveill. 2022 Oct;27(40).Full text Abstract
128. Chard AN, Dalton AF, Diallo AO, et al. Risk of clade II mpox associated with intimate and nonintimate close contact among men who have sex with men and transgender adults - United States, August 2022-July 2023. MMWR Morb Mortal Wkly Rep. 2024 Oct 10;73(40):896-902.Full text Abstract
129. Masirika LM, Zaeck LM, Ndishimye P, et al. Serological evidence of clade Ib mpox transmission by sex workers and within household in South Kivu, DRC. Nat Commun. 2025 Aug 1;16(1):7056.Full text Abstract
130. Tascini C, Geminiani M, Sbrana F, et al. Possible tattoo-transmitted monkeypox viral infection. Intern Emerg Med. 2022 Nov;17(8):2421-2.Full text Abstract
131. Del Río García V, Palacios JG, Morcillo AM, et al. Monkeypox outbreak in a piercing and tattoo establishment in Spain. Lancet Infect Dis. 2022 Sep 29;22(11):1526-8.Full text Abstract
132. Castaño-Fernández JL, Grau-Pérez M. Microblading-transmitted Monkeypox infection: fomites matter. Br J Dermatol. 2023 May 24;188(6):e40. Abstract
133. Beaumont AL, Raphaël E, Bertin C, et al. Mpox lesions on a tattoo. Lancet Infect Dis. 2023 Jun;23(6):762.Full text
134. Centers for Disease Control and Prevention. Mpox in animals and pets. Sep 2024 [internet publication].Full text
135. Huang YA, Howard-Jones AR, Durrani S, et al. Monkeypox: a clinical update for paediatricians. J Paediatr Child Health. 2022 Sep;58(9):1532-8.Full text Abstract
136. Wendorf KA, Ng R, Stainken C, et al. Household transmission of mpox to children and adolescents, California, 2022. J Infect Dis. 2023 Oct 13:jiad448.Full text Abstract
137. Centers for Disease Control and Prevention. Mpox clinical care and treatment during pregnancy. Aug 2025 [internet publication].Full text
138. Dashraath P, Nielsen-Saines K, Rimoin A, et al. Monkeypox and pregnancy: virology, clinical presentation, and obstetric management. Am J Obstet Gynecol. 2022 Dec;227(6):849-61.Full text Abstract
139. Winata IGS, Leonardo L, Sylfiasari R, et al. Unveiling the outcomes of mpox in pregnancy: a systematic review and single-arm meta-analysis. Infect Chemother. 2025 Mar;57(1):119-30.Full text Abstract
140. D'Antonio F, Pagani G, Buca D, et al. Monkeypox infection in pregnancy: a systematic review and meta-analysis. Am J Obstet Gynecol MFM. 2022 Sep 9:100747.Full text Abstract
141. Schwartz DA, Pittman PR. Mpox (monkeypox) in pregnancy: viral clade differences and their associations with varying obstetrical and fetal outcomes. viruses. 2023 Jul 28;15(8):1649.Full text Abstract
142. Sanchez Clemente N, Coles C, Paixao ES, et al. Paediatric, maternal, and congenital mpox: a systematic review and meta-analysis. Lancet Glob Health. 2024 Apr;12(4):e572-88.Full text Abstract
143. Schwartz DA. High rates of miscarriage and stillbirth among pregnant women with clade I mpox (monkeypox) are confirmed during 2023-2024 DR congo outbreak in South Kivu Province. Viruses. 2024 Jul 13;16(7):1123.Full text Abstract
144. Attieh RM, Brumble L, Elwasila SM, et al. Disseminated monkeypox infection in a kidney transplant recipient: a case report. Transplant Proc. 2023 Apr;55(3):667-71.Full text Abstract
145. Fuller R, Cederroth T, Patel G, et al. First case of rapidly fatal mpox from secondary (household) transmission in a kidney transplant recipient. Am J Transplant. 2023 Jul 28:S1600-6135(23)00594-4. Abstract
146. Pilkington V, Quinn K, Campbell L, et al. Clinical presentation of Monkeypox in people with and without HIV in the United Kingdom during the 2022 global outbreak. AIDS Res Hum Retroviruses. 2023 Nov;39(11):581-6. Abstract
147. Bragazzi NL, Kong JD, Mahroum N, et al. Epidemiological trends and clinical features of the ongoing monkeypox epidemic: a preliminary pooled data analysis and literature review. J Med Virol. 2023 Jan;95(1):e27931. Abstract
148. Ogoina D, Iroezindu M, James HI, et al. Clinical course and outcome of human monkeypox in Nigeria. Clin Infect Dis. 2020 Nov 5;71(8):e210-4.Full text Abstract
149. Kowalski J, Cielniak I, Garbacz-Łagożna E, et al. Comparison of clinical course of mpox among HIV-negative and HIV-positive patients: a 2022 cohort of hospitalized patients in Central Europe. J Med Virol. 2023 Oct;95(10):e29172. Abstract
150. Shabil M, Gaidhane S, Roopashree R, et al. Association of HIV infection and hospitalization among mpox cases: a systematic review and meta-analysis. BMC Infect Dis. 2025 Jan 22;25(1):102.Full text Abstract
151. Miller MJ, Cash-Goldwasser S, Marx GE, et al. Severe monkeypox in hospitalized patients: United States, August 10 - October 10, 2022. MMWR Morb Mortal Wkly Rep. 2022 Nov 4;71(44):1412-7.Full text Abstract
152. Triana-González S, Román-López C, Mauss S, et al. Risk factors for mortality and clinical presentation of monkeypox. AIDS. 2023 Nov 1;37(13):1979-85. Abstract
153. Mitjà O, Alemany A, Marks M, et al. Mpox in people with advanced HIV infection: a global case series. Lancet. 2023 Mar 18;401(10380):939-49.Full text Abstract
154. Thomas A, Hammarlund E, Gao L, et al. Loss of preexisting immunological memory among human immunodeficiency virus-infected women despite immune reconstitution with antiretroviral therapy. J Infect Dis. 2020 Jun 29;222(2):243-51.Full text Abstract
155. Ramoni S, Maronese CA, Morini N, et al. Syphilis and monkeypox co-infection: coincidence, synergy or asymptomatic carriage? Travel Med Infect Dis. 2022 Sep 5;50:102447.Full text Abstract
156. Xia J, Huang CL, Chu P, et al. Eczema monkeypoxicum: report of monkeypox transmission in a patient with atopic dermatitis. JAAD Case Rep. 2022 Nov;29:95-9.Full text Abstract
157. Napoli E, Frizzell M, Gravell C, et al. Eczema monkeypoxicum in a female patient with atopic dermatitis. Open Forum Infect Dis. 2023 Mar;10(3):ofad072.Full text Abstract
158. Centers for Disease Control and Prevention. Vaccine for mpox prevention in the United States. Nov 2024 [internet publication].Full text
159. Brooks JT, Marks P, Goldstein RH, et al. Intradermal vaccination for monkeypox: benefits for individual and public health. N Engl J Med. 2022 Sep 29;387(13):1151-3.Full text Abstract
160. World Health Organization. Smallpox and mpox (orthopoxviruses): WHO position paper, August 2024. Aug 2024 [internet publication].Full text
161. Frey SE, Wald A, Edupuganti S, et al. Comparison of lyophilized versus liquid modified vaccinia Ankara (MVA) formulations and subcutaneous versus intradermal routes of administration in healthy vaccinia-naïve subjects. Vaccine. 2015 Sep 22;33(39):5225-34. Abstract
162. Mazzotta V, Piselli P, Cozzi Lepri A, et al. Reactogenicity and immunogenicity against MPXV of the intradermal administration of modified vaccinia ankara compared to the standard subcutaneous route. Vaccines (Basel). 2024 Dec 31;13(1):32.Full text Abstract
163. Montalti M, Di Valerio Z, Angelini R, et al. Safety of monkeypox vaccine using active surveillance, two-center observational study in Italy. Vaccines (Basel). 2023 Jun 27;11(7):1163.Full text Abstract
164. Bavarian Nordic. Direct healthcare professional communication: letter to GB/UK healthcare professionals about the differences between Imvanex® brand (licensed in GB/UK) and Jynneos® brand (licensed in US) of live modified vaccinia virus Ankara. Sep 2022 [internet publication].Full text
165. Okumura N, Ishikane M, Ujiie M, et al. "Take" after LC16m8 for mpox. Int J Infect Dis. 2023 Sep;134:290-1.Full text
166. Tomita N, Terada-Hirashima J, Uemura Y, et al. An open-label, non-randomized study investigating the safety and efficacy of smallpox vaccine, LC16, as post-exposure prophylaxis for mpox. Hum Vaccin Immunother. 2023 Aug 1;19(2):2242219.Full text Abstract
167. World Health Organization. LC16m8 (live-attenuated freeze-dried vaccinia) smallpox and mpox vaccine: interim guidance, 22 April 2025. Apr 2025 [internet publication].Full text
168. Pittman PR, Hahn M, Lee HS, et al. Phase 3 efficacy trial of modified vaccinia Ankara as a vaccine against smallpox. N Engl J Med. 2019 Nov 14;381(20):1897-908. Abstract
169. Rao AK, Petersen BW, Whitehill F, et al. Use of JYNNEOS (smallpox and monkeypox vaccine, live, nonreplicating) for preexposure vaccination of persons at risk for occupational exposure to orthopoxviruses: recommendations of the Advisory Committee on Immunization Practices - United States, 2022. MMWR Morb Mortal Wkly Rep. 2022 Jun 3;71(22):734-42.Full text Abstract
170. Duffy J, Marquez P, Moro P, et al. Safety monitoring of JYNNEOS vaccine during the 2022 mpox outbreak: United States, May 22 - October 21, 2022. MMWR Morb Mortal Wkly Rep. 2022 Dec 9;71(49):1555-9.Full text Abstract
171. Nave L, Margalit I, Tau N, et al. Immunogenicity and safety of modified vaccinia ankara (MVA) vaccine-a systematic review and meta-analysis of randomized controlled trials. Vaccines (Basel). 2023 Aug 24;11(9):1410.Full text Abstract
172. Ryckeley C, Goodwin G, Alvarez-Calderon A. The reemerging condition of vaccinia: a case report and brief review of monkeypox and vaccinia vaccines. Am J Case Rep. 2023 Jun 11;24:e941006.Full text Abstract
173. British HIV Association. BHIVA rapid guidance on Mpox (formerly monkeypox) virus. Oct 2022 [internet publication].Full text
174. Hillus D, Le NH, Tober-Lau P, et al. Safety and effectiveness of MVA-BN vaccination against mpox in at-risk individuals in Germany (SEMVAc and TEMVAc): a combined prospective and retrospective cohort study. Lancet Infect Dis. 2025 Mar 18 [Epub ahead of print].Full text Abstract
175. Ladhani SN, Dowell AC, Jones S, et al. Early evaluation of the safety, reactogenicity, and immune response after a single dose of modified vaccinia Ankara-Bavaria Nordic vaccine against mpox in children: a national outbreak response. Lancet Infect Dis. 2023 Sep;23(9):1042-50.Full text Abstract
176. Centers for Disease Control and Prevention. Smallpox: contraindications to vaccination. Nov 2024 [internet publication].Full text
177. Badell ML, Meaney-Delman D, Tuuli MG, et al. Risks associated with smallpox vaccination in pregnancy: a systematic review and meta-analysis. Obstet Gynecol. 2015 Jun;125(6):1439-51.Full text Abstract
178. Cono J, Casey CG, Bell DM, et al. Smallpox vaccination and adverse reactions: guidance for clinicians. MMWR Recomm Rep. 2003 Feb 21;52(RR-4):1-28.Full text Abstract
179. Halsell JS, Riddle JR, Atwood JE, et al. Myopericarditis following smallpox vaccination among vaccinia-naive US military personnel. JAMA. 2003 Jun 25;289(24):3283-9.Full text Abstract
180. Dayyab FM, Daiyab HM, Farahat RA. Precautions and recommendations towards possible cardiac manifestations of monkeypox vaccination. Int J Surg. 2022 Sep;105:106898.Full text Abstract
181. Akter F, Hasan TB, Alam F, et al. Effect of prior immunisation with smallpox vaccine for protection against human monkeypox: a systematic review. Rev Med Virol. 2023 Jul;33(4):e2444.Full text Abstract
182. Criscuolo E, Giuliani B, Ferrarese R, et al. Smallpox vaccination-elicited antibodies cross-neutralize 2022-Monkeypox virus Clade II. J Med Virol. 2023 Mar;95(3):e28643.Full text Abstract
183. McCollum AM, Damon IK. Human monkeypox. Clin Infect Dis. 2014 Jan;58(2):260-7.Full text Abstract
184. Earl PL, Americo JL, Wyatt LS, et al. Immunogenicity of a highly attenuated MVA smallpox vaccine and protection against monkeypox. Nature. 2004 Mar 11;428(6979):182-5.Full text Abstract
185. Zaeck LM, Lamers MM, Verstrepen BE, et al. Low levels of monkeypox virus-neutralizing antibodies after MVA-BN vaccination in healthy individuals. Nat Med. 2023 Jan;29(1):270-8.Full text Abstract
186. Mason LMK, Betancur E, Riera-Montes M, et al. MVA-BN vaccine effectiveness: a systematic review of real-world evidence in outbreak settings. Vaccine. 2024 Oct 15;42(26):126409.Full text Abstract
187. Kandeel M, Morsy MA, Abd El-Lateef HM, et al. Efficacy of the modified vaccinia Ankara virus vaccine and the replication-competent vaccine ACAM2000 in monkeypox prevention. Int Immunopharmacol. 2023 Apr 21;119:110206.Full text Abstract
188. Selverian CN, Monticelli SR, Jaleta YM, et al. MPXV infection stimulates a more robust and durable neutralizing antibody response compared to MVA-BN vaccination. J Infect Dis. 2024 Oct 18:jiae515.Full text Abstract
189. Lim SY, Kim HS, Yim HS, et al. Comparison of waning antibody responses after natural monkeypox virus infection and mpox vaccination beyond 6 months in South Korea. Open Forum Infect Dis. 2024 Oct;11(10):ofae566.Full text Abstract
190. Collier AY, McMahan K, Jacob-Dolan C, et al. Decline of mpox antibody responses after modified vaccinia Ankara-Bavarian Nordic vaccination. JAMA. 2024 Nov 19;332(19):1669-72.Full text Abstract
191. Oom AL, Wilson KK, Yonatan M, et al. The two-dose MVA-BN mpox vaccine induces a nondurable and low avidity MPXV-specific antibody response. J Virol. 2025 Mar 31 [Epub ahead of print].Full text Abstract
192. Bravo-Vázquez LA, Bernal-Vázquez D, Duttaroy AK, et al. Current status of next-generation vaccines against mpox virus: a scoping review. Front Pharmacol. 2025 Apr 28:16:1533533.Full text Abstract
193. UK Health Security Agency. Biological principles for control of mpox in the UK: 4 nations consensus statement. Mar 2025 [internet publication].Full text
194. UK Health Security Agency. Mpox: guidance on when to suspect a case of mpox. Jun 2025 [internet publication].Full text
195. Centers for Disease Control and Prevention. Mpox case definitions. Sep 2024 [internet publication].Full text
196. Berdahl CT, Krishnadasan A, Pathmarajah K, et al. Mpox surveillance based on rash characteristics - 13 emergency departments, United States, June-December 2023. MMWR Morb Mortal Wkly Rep. 2024 Jun 6;73(22):507-13.Full text Abstract
197. Mulka L, Cassell J. The changing face of monkeypox. BMJ. 2022 Aug 10;378:o1990.Full text Abstract
198. Centers for Disease Control and Prevention. Health alert network (HAN) health advisory: severe manifestations of monkeypox among people who are immunocompromised due to HIV or other conditions. Sep 2022 [internet publication].Full text
199. Centers for Disease Control and Prevention. Clinical features of mpox. Sep 2024 [internet publication].Full text
200. Philpott D, Hughes CM, Alroy KA, et al. Epidemiologic and clinical characteristics of monkeypox cases: United States, May 17 – July 22, 2022. MMWR Morb Mortal Wkly Rep. 2022 Aug 12;71(32):1018-22.Full text Abstract
201. Patel A, Bilinska J, Tam JCH, et al. Clinical features and novel presentations of human monkeypox in a central London centre during the 2022 outbreak: descriptive case series. BMJ. 2022 Jul 28;378:e072410.Full text Abstract
202. World Health Organization. Update 79: Monkeypox outbreak update: situation - transmission - countermeasures. August 2022 [internet publication].Full text
203. Pfäfflin F, Wendisch D, Scherer R, et al. Monkeypox in-patients with severe anal pain. Infection. 2023 Apr;51(2):483-7.Full text Abstract
204. Yakubovsky M, Shasha D, Reich S, et al. Monkeypox presenting as proctitis in men who have sex with men. Clin Infect Dis. 2023 Feb 8;76(3):528-30.Full text Abstract
205. Rekik S, Pluart DL, Ferré V, et al. Anogenital symptoms and lesions in a series of 20 patients infected with monkeypox virus. Colorectal Dis. 2023 May;25(5):1002-5.Full text Abstract
206. Tarín-Vicente EJ, Alemany A, Agud-Dios M, et al. Clinical presentation and virological assessment of confirmed human monkeypox virus cases in Spain: a prospective observational cohort study. Lancet. 2022 Aug 27;400(10353):661-9.Full text Abstract
207. Shah J, Saak TM, Desai AN, et al. Otolaryngologic manifestations among MPOX patients: a systematic review and meta-analysis. Am J Otolaryngol. 2023 Nov-Dec;44(6):103991. Abstract
208. Wawina-Bokalanga T, Merritt S, Kinganda-Lusamaki E, et al. Epidemiology and phylogenomic characterisation of two distinct mpox outbreaks in Kinshasa, DR Congo, involving a new subclade Ia lineage: a retrospective, observational study. Lancet. 2025 Jul 5;406(10498):63-75. Abstract
209. Boesecke C, Monin MB, van Bremen K, et al. Severe monkeypox-virus infection in undiagnosed advanced HIV infection. Infection. 2022 Dec;50(6):1633-4.Full text Abstract
210. Chastain DB, Motoa G, Ortiz-Martínez Y, et al. Characteristics and clinical manifestations of monkeypox among people with and without HIV in the United States: a retrospective cohort. AIDS. 2023 Mar 15;37(4):611-6. Abstract
211. Angelo KM, Smith T, Camprubí-Ferrer D, et al. Epidemiological and clinical characteristics of patients with monkeypox in the GeoSentinel Network: a cross-sectional study. Lancet Infect Dis. 2023 Feb;23(2):196-206.Full text Abstract
212. Girometti N, Byrne R, Bracchi M, et al. Demographic and clinical characteristics of confirmed human monkeypox virus cases in individuals attending a sexual health centre in London, UK: an observational analysis. Lancet Infect Dis. 2022 Sep;22(9):1321-8.Full text Abstract
213. European Centre for Disease Prevention and Control. Monkeypox cases reported in UK and Portugal. May 2022 [internet publication].Full text
214. Patrocinio-Jesus R, Peruzzu F. Monkeypox genital lesions. N Engl J Med. 2022 Jul 7;387(1):66.Full text Abstract
215. Orviz E, Negredo A, Ayerdi O, et al. Monkeypox outbreak in Madrid (Spain): clinical and virological aspects. J Infect. 2022 Oct;85(4):412-7.Full text Abstract
216. Català A, Clavo Escribano P, Riera J, et al. Monkeypox outbreak in Spain: clinical and epidemiological findings in a prospective cross-sectional study of 185 cases. Br J Dermatol. 2022 Nov;187(5):765-72.Full text Abstract
217. Quattri E, Avallone G, Maronese CA, et al. Unilesional monkeypox: a report of two cases from Italy. Travel Med Infect Dis. 2022 Aug 10;49:102424.Full text Abstract
218. Ciccarese G, Brucci G, Di Biagio A, et al. Two cases of monkeypox virus infection without detectable cutaneous/mucosal lesions. Travel Med Infect Dis. 2023 Jul-Aug;54:102605.Full text
219. Ardila CM, Arrubla-Escobar DE, Vivares-Builes AM. Oral lesions in patients with human monkeypox: a systematic scoping review. J Oral Pathol Med. 2023 Jul;52(6):459-67. Abstract
220. Mishra S, Khan R, Krizova A, et al. Esophageal monkeypox lesion. Clin Gastroenterol Hepatol. 2023 Jan;21(1):A17-8.Full text Abstract
221. Williams G, Watters C, Watson N. Auricular manifestation of mpox (monkeypox). BMJ Case Rep. 2023 Jan 19;16(1):e252931.Full text Abstract
222. Portela-Dias J, Sereno S, Falcão-Reis I, et al. Monkeypox infection with localized genital lesions in women. Am J Obstet Gynecol. 2022 Dec;227(6):906.Full text Abstract
223. Vallée A, Chatelain A, Carbonnel M, et al. Monkeypox virus infection in 18-year-old woman after sexual intercourse, France, September 2022. Emerg Infect Dis. 2022 Nov 10;29(1).Full text Abstract
224. Zayat N, Huang S, Wafai J, et al. Monkeypox virus infection in 22-year-old woman after sexual intercourse, New York, USA. Emerg Infect Dis. 2022 Nov 10;29(1).Full text Abstract
225. Ramírez M, Delso V, Sánchez MJ, et al. Mpox (monkeypox) presenting as cervical and vulvar disease. Obstet Gynecol. 2023 Mar 1;141(3):613-7. Abstract
226. Prasad S, Casas CG, Strahan AG, et al. A dermatologic assessment of 101 mpox (monkeypox) cases from 13 countries during the 2022 outbreak: skin lesion morphology, clinical course, and scarring. J Am Acad Dermatol. 2023 May;88(5):1066-73.Full text Abstract
227. Gomez-Garberi M, Sarrio-Sanz P, Martinez-Cayuelas L, et al. Genitourinary lesions due to monkeypox. Eur Urol. 2022 Dec;82(6):625-30.Full text Abstract
228. Simon-Gozalbo A, Gamo-Guerrero M, Alonso-Garcia S, et al. Haemorrhagic monkeypox infection in an immunosuppressed patient with human immunodeficiency virus: beyond the pustules. Clin Microbiol Infect. 2023 Jan;29(1):122-4.Full text Abstract
229. Hoffmann C, Wolf E, Jessen H, et al. Is there any evidence for milder courses of monkeypox virus infections with childhood smallpox vaccination? Infection. 2023 Apr;51(2):535-6.Full text Abstract
230. Rao AK, Schrodt CA, Minhaj FS, et al. Interim clinical treatment considerations for severe manifestations of mpox: United States, February 2023. MMWR Morb Mortal Wkly Rep. 2023 Mar 3;72(9):232-43.Full text Abstract
231. Centers for Disease Control and Prevention. Clinical treatment of mpox. Aug 2025 [internet publication].Full text
232. World Health Organization. Diagnostic testing for the monkeypox virus (MPXV): interim guidance. May 2024 [internet publication].Full text
233. UK Health Security Agency. Mpox: diagnostic testing. Apr 2025 [internet publication].Full text
234. Altindis M, Puca E, Shapo L. Diagnosis of monkeypox virus: an overview. Travel Med Infect Dis. 2022 Sep 13;50:102459.Full text Abstract
235. Gul I, Liu C, Yuan X, et al. Current and perspective sensing methods for monkeypox virus. Bioengineering (Basel). 2022 Oct 18;9(10):571.Full text Abstract
236. Centers for Disease Control and Prevention. Guidelines for collecting and handling specimens for mpox testing. Sep 2024 [internet publication].Full text
237. Minhaj FS, Petras JK, Brown JA, et al. Orthopoxvirus testing challenges for persons in populations at low risk or without known epidemiologic link to monkeypox: United States, 2022. MMWR Morb Mortal Wkly Rep. 2022 Sep 9;71(36):1155-8.Full text Abstract
238. Paran N, Yahalom-Ronen Y, Shifman O, et al. Monkeypox DNA levels correlate with virus infectivity in clinical samples, Israel, 2022. Euro Surveill. 2022 Sep;27(35).Full text Abstract
239. McQuiston JH, Luce R, Kazadi DM, et al. U.S. preparedness and response to increasing clade I mpox cases in the Democratic Republic of the Congo - United States, 2024. MMWR Morb Mortal Wkly Rep. 2024 May 16;73(19):435-40.Full text Abstract
240. Martins-Filho PR, Tanajura DM, Alves Dos Santos C. Polymerase chain reaction positivity and cycle threshold values in biological samples from patients with monkeypox: a meta-analysis. Travel Med Infect Dis. 2022 Sep 7;50:102448.Full text Abstract
241. Hasso M, Perusini S, Eshaghi A, et al. Monkeypox virus detection in different clinical specimen types. Emerg Infect Dis. 2022 Oct 12;28(12).Full text Abstract
242. Nörz D, Brehm TT, Tang HT, et al. Clinical characteristics and comparison of longitudinal qPCR results from different specimen types in a cohort of ambulatory and hospitalized patients infected with monkeypox virus. J Clin Virol. 2022 Aug 11;155:105254.Full text Abstract
243. US Food and Drug Administration. For monkeypox testing, use lesion swab samples to avoid false results: FDA safety communication. Jul 2022 [internet publication].Full text
244. Veintimilla C, Catalán P, Alonso R, et al. The relevance of multiple clinical specimens in the diagnosis of monkeypox virus, Spain, June 2022. Euro Surveill. 2022 Aug;27(33).Full text Abstract
245. Allan-Blitz LT, Carragher K, Sukhija-Cohen A, et al. Laboratory validation and clinical performance of a saliva-based test for monkeypox virus. J Med Virol. 2023 Jan;95(1):e28191.Full text Abstract
246. Messina MD, Wolf EL, Kanmaniraja D, et al. Imaging features of anorectal proctitis in monkeypox infection. Clin Imaging. 2022 Dec;92:109-11.Full text Abstract
247. Titanji BK, Tegomoh B, Nematollahi S, et al. Monkeypox: a contemporary review for healthcare professionals. Open Forum Infect Dis. 2022 Jul;9(7):ofac310.Full text Abstract
248. El Eid R, Allaw F, Haddad SF, et al. Human monkeypox: a review of the literature. PLoS Pathog. 2022 Sep;18(9):e1010768.Full text Abstract
249. Centers for Disease Control and Prevention. Additional testing of biopsy tissues in severe mpox infections. Sep 2024 [internet publication].Full text
250. Sui Y, Xu Q, Liu M, et al. CRISPR-Cas12a-based detection of monkeypox virus. J Infect. 2022 Dec;85(6):702-69.Full text Abstract
251. Feng J, Xue G, Cui X, et al. Development of a loop-mediated isothermal amplification method for rapid and visual detection of monkeypox virus. Microbiol Spectr. 2022 Sep 26:e0271422.Full text Abstract
252. Thieme AH, Zheng Y, Machiraju G, et al. A deep-learning algorithm to classify skin lesions from mpox virus infection. Nat Med. 2023 Mar;29(3):738-47.Full text Abstract
253. Hussain A, Kaler J, Lau G, et al. Clinical conundrums: differentiating monkeypox from similarly presenting infections. Cureus. 2022 Oct;14(10):e29929.Full text Abstract
254. El-Qushayri AE, Reda A, Shah J. COVID-19 and monkeypox co-infection: a rapid systematic review. Front Immunol. 2022 Dec 14;13:1094346.Full text Abstract
255. Kaiser RM, Cash-Goldwasser S, Lehnertz N, et al. Pharyngeal co-infections with monkeypox virus and group A streptococcus, United States, 2022. Emerg Infect Dis. 2023 Sep;29(9):1855-8.Full text Abstract
256. Satapathy P, Gaidhane AM, Vadia N, et al. Proctitis and other gastrointestinal manifestations in mpox disease: a systematic review and meta-analysis. JGH Open. 2025 Jun;9(6):e70190.Full text Abstract
257. Nkengurutse L, Otshudiema JO, Kamwenubusa G, et al. Clinical predictors and determinants of mpox complications in hospitalized patients: a prospective cohort study from Burundi. Viruses. 2025 Mar 27;17(4):480.Full text Abstract
258. Oprea C, Ionuț Popa, Ianache I, et al. Monkeypox, severe hepatitis A, and syphilis in an HIV returning traveler from Spain to Romania. Travel Med Infect Dis. 2022 Sep 8:102455.Full text Abstract
259. Ola D, Dane B, Shanbhogue K, et al. Rectal and perirectal CT findings in patients with monkeypox virus infection. Abdom Radiol (NY). 2023 Jul;48(7):2284-91. Abstract
260. Martins-Filho PR, Dorea FCM, Sena LOC, et al. First reports of monkeypox and varicella-zoster virus coinfection in the global human monkeypox outbreak in 2022. Travel Med Infect Dis. 2023 Jan-Feb;51:102510.Full text Abstract
261. Hughes CM, Liu L, Davidson WB, et al. A tale of two viruses: coinfections of monkeypox and varicella zoster virus in the Democratic Republic of Congo. Am J Trop Med Hyg. 2020 Dec 7;104(2):604-11.Full text Abstract
262. Liu Y, Li X, Yan H, et al. A case of orf virus infection in the human: other zoonotic poxvirus infection events should not be ignored during the mpox epidemic. Travel Med Infect Dis. 2023 May-Jun;53:102588.Full text
263. UK Health Security Agency. Contact tracing guidance for mpox. Apr 2025 [internet publication].Full text
264. Centers for Disease Control and Prevention. Mpox infection prevention and control in healthcare settings. Jul 2025 [internet publication].Full text
265. Centers for Disease Control and Prevention. Diagnostic testing for mpox. Aug 2024 [internet publication].Full text
266. World Health Organization. Risk assessment tool for identifying and managing health and care workers with a potential occupational exposure to monkeypox virus. Jan 2025 [internet publication].Full text
267. Australian Government Department of Health: Australian Centre for Disease Control. Mpox. Aug 2025 [internet publication].Full text
268. UK Health Security Agency. Mpox: background information. May 2025 [internet publication].Full text
269. Webb E, Rigby I, Michelen M, et al. Availability, scope and quality of monkeypox clinical management guidelines globally: a systematic review. BMJ Glob Health. 2022 Aug;7(8):e009838.Full text Abstract
270. Centers for Disease Control and Prevention. Clinical considerations for pain management. Sep 2024 [internet publication].Full text
271. Hans GH, Wildemeersch D, Meeus I. Integrated analgesic care in the current human monkeypox outbreak: perspectives on an integrated and holistic approach combining old allies with innovative technologies. Medicina (Kaunas). 2022 Oct 15;58(10):1454.Full text Abstract
272. Lucar J, Roberts A, Saardi KM, et al. Monkeypox virus-associated severe proctitis treated with oral tecovirimat: a report of two cases. Ann Intern Med. 2022 Nov;175(11):1626-7.Full text Abstract
273. Hallo-Carrasco A, Hunt CL, Prusinski CC, et al. Pain associated with monkeypox virus: a rapid review. Cureus. 2023 Feb;15(2):e34697.Full text Abstract
274. Maredia H, Sartori-Valinotti JC, Ranganath N, et al. Supportive care management recommendations for mucocutaneous manifestations of monkeypox infection. Mayo Clin Proc. 2023 Jun;98(6):828-32.Full text Abstract
275. de Sousa D, Frade J, Patrocínio J, et al. Monkeypox infection and bacterial cellulitis: a complication to look for. Int J Infect Dis. 2022 Oct;123:180-2.Full text Abstract
276. American Academy of Dermatology Association. Mpox: treating severe lesions [internet publication].Full text
277. Reda A, Hemmeda L, Brakat AM, et al. The clinical manifestations and severity of the 2022 monkeypox outbreak among 4080 patients. Travel Med Infect Dis. 2022 Nov-Dec;50:102456.Full text Abstract
278. Fink DL, Callaby H, Luintel A, et al. Clinical features and management of individuals admitted to hospital with monkeypox and associated complications across the UK: a retrospective cohort study. Lancet Infect Dis. 2023 May;23(5):589-97.Full text Abstract
279. DeWitt ME, Polk C, Williamson J, et al. Global monkeypox case hospitalisation rates: a rapid systematic review and meta-analysis. EClinicalMedicine. 2022 Dec;54:101710.Full text Abstract
280. de Oliveira-Júnior JM, Tenório MDL, Dos Santos Caduda S, et al. Reasons for hospitalization of patients with monkeypox: a quantitative evidence synthesis. Infection. 2023 Jun;51(3):789-91. Abstract
281. Siegrist EA, Sassine J. Antivirals with activity against monkeypox: a clinically oriented review. Clin Infect Dis. 2023 Jan 6;76(1):155-64.Full text Abstract
282. Shamim MA, Padhi BK, Satapathy P, et al. The use of antivirals in the treatment of human monkeypox outbreaks: a systematic review. Int J Infect Dis. 2023 Feb;127:150-61.Full text Abstract
283. Smith TG, Gigante CM, Wynn NT, et al. Tecovirimat resistance in mpox patients, United States, 2022-2023. Emerg Infect Dis. 2023 Oct 19;29(12).Full text Abstract
284. Mertes H, Rezende AM, Brosius I, et al. Tecovirimat resistance in an immunocompromised patient with mpox and prolonged viral shedding. Ann Intern Med. 2023 Aug;176(8):1141-3.Full text
285. Gigante CM, Takakuwa J, McGrath D, et al. Notes from the field: mpox cluster caused by tecovirimat-resistant monkeypox virus - five states, October 2023-February 2024. MMWR Morb Mortal Wkly Rep. 2024 Oct 10;73(40):903-5.Full text Abstract
286. Seifu L, Garcia E, McPherson TD, et al. Notes from the field: posttreatment lesions after tecovirimat treatment for Mpox - New York City, August-September 2022. MMWR Morb Mortal Wkly Rep. 2023 Apr 28;72(17):471-2.Full text Abstract
287. Fox T, Gould S, Princy N, et al. Therapeutics for treating mpox in humans. Cochrane Database Syst Rev. 2023 Mar 14;(3):CD015769.Full text Abstract
288. ClinicalTrials.gov. A trial to assess the safety, tolerability, and pharmacokinetics of the anti-orthopoxvirus compound tecovirimat (SIGA246-008). Nov 2017 [internet publication].Full text
289. Grosenbach DW, Honeychurch K, Rose EA, et al. Oral tecovirimat for the treatment of smallpox. N Engl J Med. 2018 Jul 5;379(1):44-53.Full text Abstract
290. Adler H, Gould S, Hine P, et al. Clinical features and management of human monkeypox: a retrospective observational study in the UK. Lancet Infect Dis. 2022 Aug;22(8):1153-62.Full text Abstract
291. Matias WR, Koshy JM, Nagami EH, et al. Tecovirimat for the treatment of human monkeypox: an initial series from Massachusetts, United States. Open Forum Infect Dis. 2022 Aug;9(8):ofac377.Full text Abstract
292. Desai AN, Thompson GR 3rd, Neumeister SM, et al. Compassionate use of tecovirimat for the treatment of monkeypox infection. JAMA. 2022 Oct 4;328(13):1348-150.Full text Abstract
293. O'Laughlin K, Tobolowsky FA, Elmor R, et al. Clinical use of tecovirimat (Tpoxx) for treatment of monkeypox under an investigational new drug protocol: United States, May - August 2022. MMWR Morb Mortal Wkly Rep. 2022 Sep 16;71(37):1190-5.Full text Abstract
294. Viguier C, de Kermel T, Boumaza X, et al. A severe monkeypox infection in a patient with an advanced HIV infection treated with tecovirimat: clinical and virological outcome. Int J Infect Dis. 2022 Oct 29;125:135-7.Full text Abstract
295. Mbrenga F, Nakouné E, Malaka C, et al. Tecovirimat for monkeypox in Central African Republic under expanded access. N Engl J Med. 2022 Dec 15;387(24):2294-5.Full text Abstract
296. Wu EL, Osborn RL, Bertram CM, et al. Tecovirimat use in ambulatory and hospitalized patients with monkeypox virus infection. Sex Transm Dis. 2023 Mar 1;50(3):172-4. Abstract
297. Hermanussen L, Brehm TT, Wolf T, et al. Tecovirimat for the treatment of severe mpox in Germany. Infection. 2023 Oct;51(5):1563-8.Full text Abstract
298. PALM007 Writing Group; Ali R, Alonga J, Biampata JL, et al. Tecovirimat for clade I MPXV infection in the Democratic Republic of Congo. N Engl J Med. 2025 Apr 17;392(15):1484-96.Full text Abstract
299. National Institute of Allergy and Infectious Diseases. NIH study finds tecovirimat was safe but did not improve mpox resolution or pain. Dec 2024 [internet publication]. Full text
300. MPX-RESPONSE. Large international trial UNITY reports no clinical benefit from tecovirimat for mpox resolution. Jul 2025 [internet publication].Full text
301. McLean J, Stoeckle K, Huang S, et al. Tecovirimat treatment of people with HIV during the 2022 mpox outbreak: a retrospective cohort study. Ann Intern Med. 2023 May;176(5):642-8.Full text Abstract
302. Aldred B, Lyles RH, Scott JY, et al. Early tecovirimat treatment for mpox disease among people with HIV. JAMA Intern Med. 2024 Mar 1;184(3):275-9. Abstract
303. Stittelaar KJ, Neyts J, Naesens L, et al. Antiviral treatment is more effective than smallpox vaccination upon lethal monkeypox virus infection. Nature. 2006 Feb 9;439(7077):745-8.Full text Abstract
304. Huggins J, Goff A, Hensley L, et al. Nonhuman primates are protected from smallpox virus or monkeypox virus challenges by the antiviral drug ST-246. Antimicrob Agents Chemother. 2009 Jun;53(6):2620-5.Full text Abstract
305. Fabrizio C, Bruno G, Cristiano L, et al. Cidofovir for treating complicated monkeypox in a man with acquired immune deficiency syndrome. Infection. 2023 Apr;51(2):519-22. Abstract
306. Raccagni AR, Candela C, Bruzzesi E, et al. Real-life use of cidofovir for the treatment of severe monkeypox cases. J Med Virol. 2023 Jan;95(1):e28218. Abstract
307. Mondi A, Gagliardini R, Mazzotta V, et al. Clinical experience with use of oral tecovirimat or intravenous cidofovir for the treatment of monkeypox in an Italian reference hospital. J Infect. 2023 Jan;86(1):66-117.Full text Abstract
308. Labate L, Brucci G, Ciccarese G, et al. Nasal monkeypox virus infection successfully treated with cidofovir in a patient newly diagnosed with HIV. Int J STD AIDS. 2023 Mar;34(3):208-10. Abstract
309. Stafford A, Rimmer S, Gilchrist M, et al. Use of cidofovir in a patient with severe mpox and uncontrolled HIV infection. Lancet Infect Dis. 2023 Jun;23(6):e218-26.Full text Abstract
310. UK Health Security Agency. De-isolation and discharge of mpox-infected patients. Apr 2025 [internet publication].Full text
311. Sampson MM, Magee G, Schrader EA, et al. Mpox (Monkeypox) infection during pregnancy. Obstet Gynecol. 2023 May 1;141(5):1007-10. Abstract
312. Dashraath P, Nielsen-Saines K, Mattar C, et al. Guidelines for pregnant individuals with monkeypox virus exposure. Lancet. 2022 Jul 2;400(10345):21-2.Full text Abstract
313. Khalil A, Samara A, O'Brien P, et al. Monkeypox and pregnancy: what do obstetricians need to know? Ultrasound Obstet Gynecol. 2022 Jul;60(1):22-7.Full text Abstract
314. Raccagni AR, Mileto D, Galli L, et al. HIV viral load monitoring during monkeypox virus infection among PLWH. AIDS. 2023 Apr 1;37(5):779-83. Abstract
315. National Institutes of Health; Centers for Disease Control and Prevention; HIV Medicine Association; Infectious Diseases Society of America. Panel on Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV. Guidelines for the prevention and treatment of opportunistic infections in adults and adolescents with HIV: Mpox. 2025 [internet publication].Full text
316. Mazurkov OY, Kabanov AS, Shishkina LN, et al. New effective chemically synthesized anti-smallpox compound NIOCH-14. J Gen Virol. 2016 May;97(5):1229-39.Full text Abstract
317. Sobral-Costas TG, Escudero-Tornero R, Servera-Negre G, et al. Human monkeypox outbreak: epidemiological data and therapeutic potential of topical cidofovir in a prospective cohort study. J Am Acad Dermatol. 2023 May;88(5):1074-82.Full text Abstract
318. Rubio-Muniz CA, Montero-Menárguez J, López-Valle A, et al. Monkeypox: is topical cidofovir a good idea? Clin Exp Dermatol. 2023 Feb 2;48(2):132-4. Abstract
319. Infectious Diseases Society of America; HIV Medicine Association. Mpox in the US: resources for HIV clinicians. Dec 2022 [internet publication].Full text
320. World Health Organization. Mpox (monkeypox) outbreak toolbox. Feb 2025 [internet publication].Full text
321. UK Health Security Agency. Mpox: guidance. Jun 2025 [internet publication].Full text
322. UK Health Security Agency. Mpox: guidance for people who are isolating at home. Jun 2025 [internet publication].Full text
323. Berens-Riha N, Bracke S, Rutgers J, et al. Persistent morbidity in Clade IIb mpox patients: interim results of a long-term follow-up study, Belgium, June to November 2022. Euro Surveill. 2023 Feb;28(7):2300072.Full text Abstract
324. Alaithan H, Venkatesh N, Kulkarni PA, et al. A case of persistently positive mpox PCR for 1 year in a patient with advanced HIV. Open Forum Infect Dis. 2025 May;12(5):ofaf230.Full text Abstract
325. Eustaquio PC, Salmon-Trejo LAT, McGuire LC, et al. Epidemiologic and clinical features of mpox in adults aged >50 years: United States, May 2022 - May 2023. MMWR Morb Mortal Wkly Rep. 2023 Aug 18;72(33):893-6.Full text Abstract
326. Riser AP, Hanley A, Cima M, et al. Epidemiologic and clinical features of mpox-associated deaths - United States, May 10, 2022-March 7, 2023. MMWR Morb Mortal Wkly Rep. 2023 Apr 14;72(15):404-10.Full text Abstract
327. Menezes YR, Miranda AB. Severe disseminated clinical presentation of monkeypox virus infection in an immunosuppressed patient: first death report in Brazil. Rev Soc Bras Med Trop. 2022 Aug 29;55:e0392.Full text Abstract
328. Sah R, Mohanty A, Abdelaal A, et al. First Monkeypox deaths outside Africa: no room for complacency. Ther Adv Infect Dis. 2022 Jan-Dec;9:20499361221124027.Full text Abstract
329. Filippov E, Duhan S, Lehman L, et al. Treatment failure in patient with severe mpox and untreated HIV, Maryland, USA. Emerg Infect Dis. 2023 Jun;29(6):1262-5.Full text Abstract
330. Golden J, Harryman L, Crofts M, et al. Case of apparent mpox reinfection. Sex Transm Infect. 2023 Jun;99(4):283-4.Full text Abstract
331. Musumeci S, Najjar I, Boffi El Amari E, et al. A case of mpox reinfection. Clin Infect Dis. 2023 Jul 5;77(1):135-7.Full text Abstract
332. Zeggagh J, Ferraris O, Salmona M, et al. Second clinical episode of hMPX virus in a man having sex with men. Lancet. 2023 May 13;401(10388):1610. Abstract
333. Álvarez-López P, Borras-Bermejo B, López Pérez L, et al. Suspected case of monkeypox reinfection versus reactivation in a immunocompetent patient, Barcelona, 2022. Int J STD AIDS. 2023 Aug;34(9):649-52. Abstract
334. Rocha SQ, Fonsi M, Tancredi MV, et al. Mpox in a couple living with HIV: relapse or reinfection? AIDS Res Hum Retroviruses. 2023 Nov;39(11):610-5. Abstract
335. Hazra A, Zucker J, Bell E, et al. Mpox in people with past infection or a complete vaccination course: a global case series. Lancet Infect Dis. 2023 Sep 4:S1473-3099(23)00492-9.Full text Abstract
336. Di Bari S, Mondi A, Pinnetti C, et al. A case of severe mpox complicated with streptococcus pyogenes sepsis in a patient with HIV infection. Pathogens. 2023 Aug 23;12(9):1073.Full text Abstract
337. Evans L, Rhodes A, Alhazzani W, et al. Surviving Sepsis Campaign: international guidelines for management of sepsis and septic shock 2021. Crit Care Med. 2021 Nov 1;49(11):e1063-143.Full text Abstract
338. Mailhe M, Beaumont AL, Thy M, et al. Clinical characteristics of ambulatory and hospitalised patients with monkeypox virus infection: an observational cohort study. Clin Microbiol Infect. 2023 Feb;29(2):233-9.Full text Abstract
339. Frade JV, Sousa I, Marques T, et al. Acute paronychia: an atypical presentation of monkeypox infection. Enferm Infecc Microbiol Clin. 2023 May;41(5):317-8.Full text Abstract
340. Smith K, Tyson K, Hossain R, et al. Progressively confluent monkeypox lesions with necrosis. Oxf Med Case Reports. 2023 Jan 18;2023(1):omac153.Full text Abstract
341. Li H, Maddy A, Patel BM, et al. Hypertrophic verrucous mpox as a sign of disease progression. JAAD Case Rep. 2023 Aug;38:38-40.Full text
342. Grau-Echevarría A, Blaya-Imbernón D, Finello M, et al. Atypical mucocutaneous manifestations of MPOX: a systematic review. J Dermatol. 2025 Feb;52(2):228-38.Full text Abstract
343. Farley R, Sarver J, Milliner B, et al. Genital infection from monkeypox virus requiring surgical debridement and scrotoplasty in an immunocompromised patient. Urol Case Rep. 2023 Jul;49:102438. Abstract
344. Gaertner F, Preissner S, Petri WA Jr, et al. Comparison of the risk of hospital admission, need for ventilation, sepsis, pneumonitis and death among the recent monkeypox outbreak and historical outbreaks. BMC Infect Dis. 2023 Sep 18;23(1):610.Full text Abstract
345. Dumont M, Guilhou T, Gerin M, et al. Myocarditis in monkeypox-infected patients: a case series. Clin Microbiol Infect. 2023 Mar;29(3):390.e5-7.Full text Abstract
346. Jaiswal V, Sultana Q, Lahori S, et al. Monkeypox-induced myocarditis: a systematic review. Curr Probl Cardiol. 2023 May;48(5):101611.Full text Abstract
347. Maqbool KU, Arsh H, Kumar D, et al. Cardiovascular manifestations of human monkeypox virus: an updated review. Curr Probl Cardiol. 2023 Jun 9;48(10):101869.Full text Abstract
348. Rayati Damavandi A, Semnani F, Hassanpour K. A review of monkeypox ocular manifestations and complications: insights for the 2022 outbreak. Ophthalmol Ther. 2023 Feb;12(1):55-69.Full text Abstract
349. Carvalho EM, Medeiros M, Veloso VG, et al. Monkeypox infection causing conjunctival vesicles and anterior uveitis. Ocul Immunol Inflamm. 2024 Apr;32(3):266-7. Abstract
350. Rohilla S, Gaidhane S, Balaraman AK, et al. Ophthalmic manifestations of the Mpox virus: a systematic review and meta-analysis. J Infect Dis. 2025 Feb 6 [Epub ahead of print]. Abstract
351. Mukit FA, Louie EM, Cape HT, et al. A suspected case of a neonatal monkeypox infection with ocular involvement. Cureus. 2023 May;15(5):e38819.Full text Abstract
352. Nguyen MT, Mentreddy A, Schallhorn J, et al. Isolated ocular Mpox without skin lesions, United States. Emerg Infect Dis. 2023 May 2;29(6):10. Abstract
353. Centers for Disease Control and Prevention. Interim clinical considerations for management of ocular mpox. Sep 2024 [internet publication].Full text
354. Finamor LPS, de Freitas D, Andrade G, et al. Tecovirimat treatment for monkeypox virus keratouveitis. JAMA Ophthalmol. 2023 Feb 1;141(2):210-2.Full text Abstract
355. Perzia B, Theotoka D, Li K, et al. Treatment of ocular-involving monkeypox virus with topical trifluridine and oral tecovirimat in the 2022 monkeypox virus outbreak. Am J Ophthalmol Case Rep. 2023 Mar;29:101779.Full text Abstract
356. Davido B, D'Anglejan E, Baudoin R, et al. Monkeypox outbreak 2022: an unusual case of peritonsillar abscess in a person previously vaccinated against smallpox. J Travel Med. 2022 Sep 17;29(6):taac082. Abstract
357. Mathieson T, Dulguerov N, Mermod M. Monkeypox mucosal lesions. IDCases. 2022 Aug 17;29:e01600.Full text Abstract
358. Meng X. Clinical manifestations of the pharynx in human monkeypox. Travel Med Infect Dis. 2022 Sep 26;50:102465.Full text Abstract
359. Mahtani AU, Engome YM, Haider M, et al. Paraphimosis as a complication of monkeypox infection. J Surg Case Rep. 2022 Nov;2022(11):rjac533.Full text Abstract
360. Milano E, Belati A, De Santis L, et al. First case of paraphimosis as a severe complication of monkeypox. Vaccines (Basel). 2022 Dec 28;11(1):63.Full text Abstract
361. Poole M, Mehrmal S, Kremer M, et al. An atypical presentation of monkeypox associated with scrotal and penile shaft edema. JAAD Case Rep. 2023 Mar:33:36-8.Full text Abstract
362. Kapmaz M, Uymaz DS, Özcan G, et al. A complicated case of monkeypox and viral shedding characteristics. J Infect. 2023 Jan;86(1):66-117.Full text Abstract
363. Brown L, Delaney C, Hainsworth A. Monkeypox-associated proctitis and rectal wall perforation. BMJ Case Rep. 2023 Jan 17;16(1):e252168.Full text Abstract
364. Saleh H, Ho BT, Call JT, et al. Severe Mpox proctitis complicated by bowel obstruction. ACG Case Rep J. 2023 May;10(5):e01048.Full text Abstract
365. Taj S, Austin C, Hussain A, et al. Severe gastrointestinal hemorrhage due to monkeypox virus-associated proctocolitis. Case Rep Gastrointest Med. 2023;2023:9981631.Full text Abstract
366. Hackett N, Narayan P, Huf S. Mpox (monkeypox) causing penile lesions and acute urinary retention. BMJ Case Rep. 2022 Dec 14;15(12):e252696.Full text Abstract
367. Fonti M, Mader T, Burmester-Kiang J, et al. Monkeypox associated acute arthritis. Lancet Rheumatol. 2022 Nov;4(11):e804.Full text Abstract
368. Lombès A, Zmerli M, Nerozzi-Banfi E, et al. Arthritis due to monkeypox virus: a case report. Joint Bone Spine. 2022 Nov 18;90(2):105492.Full text Abstract
369. Badenoch JB, Conti I, Rengasamy ER, et al. Neurological and psychiatric presentations associated with human monkeypox virus infection: a systematic review and meta-analysis. EClinicalMedicine. 2022 Oct;52:101644.Full text Abstract
370. Billioux BJ, Mbaya OT, Sejvar J, et al. Neurologic complications of smallpox and monkeypox: a review. JAMA Neurol. 2022 Nov 1;79(11):1180-6.Full text Abstract
371. Deb S, Mondal R, Sen P, et al. Neuroinflammatory disorders of the central nervous system associated with monkeypox virus: a systematic review and call to action. BMC Med. 2025 Feb 12;23(1):86.Full text Abstract
372. Money KM, Barnett TA, Rapaka S, et al. Monkeypox-associated central nervous system disease: a case series and review. Ann Neurol. 2023 May;93(5):893-905.Full text Abstract
373. Pastula DM, Copeland MJ, Hannan MC, et al. Two cases of monkeypox-associated encephalomyelitis: Colorado and the District of Columbia, July - August 2022. MMWR Morb Mortal Wkly Rep. 2022 Sep 23;71(38):1212-5.Full text Abstract
374. Cole J, Choudry S, Kular S, et al. Monkeypox encephalitis with transverse myelitis in a female patient. Lancet Infect Dis. 2023 Mar;23(3):e115-20.Full text Abstract
375. Khan SA, Parajuli SB, Rauniyar VK. Neurological manifestations of an emerging zoonosis-human monkeypox virus: a systematic review. Medicine (Baltimore). 2023 Sep 1;102(35):e34664.Full text Abstract
376. Abdul Hamid T, Mustafa N, Zulfiquar Parkar A, et al. Manifestation of guillain-barre syndrome in a case of monkeypox virus infection: a rare case report. Case Rep Infect Dis. 2023;2023:2426659.Full text Abstract
377. Nimura CA, Milani C, Tan ET, et al. Parsonage-Turner syndrome following monkeypox infection and vaccination. Skeletal Radiol. 2023 Sep;52(9):1781-4.Full text Abstract
378. Warner NC, Shishido A, Fulco PP, et al. Immune reconstitution inflammatory syndrome due to monkeypox in two patients with AIDS. AIDS. 2023 Jun 1;37(7):1187-8. Abstract
379. Abdulkarim B, Ticknor IL, Torres AR, et al. Cutaneous findings of fulminant monkeypox in a patient with HIV/AIDS. JAAD Case Rep. 2023 Aug;38:32-4.Full text
380. Pinnetti C, Cimini E, Mazzotta V, et al. Mpox as AIDS-defining event with a severe and protracted course: clinical, immunological, and virological implications. Lancet Infect Dis. 2023 Sep 28:S1473-3099(23)00482-6.Full text Abstract
381. Calin R, Périllaud-Dubois C, Marot S, et al. Mpox hepatic and pulmonary lesions in HIV/hepatitis B virus co-infected patient, France. Emerg Infect Dis. 2024 Nov;30(11):2445-7.Full text Abstract
382. Courdurié A, Buscot M, Gonfrier G, et al. MPox virus: an unusual aetiology of peritonitis. Sex Transm Infect. 2023 Jun;99(4):285-6. Abstract
383. Ssemmondo E, Idris MA, Mawer D, et al. Subacute thyroiditis following mpox infection in a patient with human immunodeficiency virus. Endocrinol Diabetes Metab Case Rep. 2023 Aug 16;2023(3):23-0034.Full text Abstract
384. Centers for Disease Control and Prevention. Isolation and infection control at home. Sep 2024 [internet publication].Full text
385. Seang S, Burrel S, Todesco E, et al. Evidence of human-to-dog transmission of monkeypox virus. Lancet. 2022 Aug 27;400(10353):658-9.Full text Abstract
386. Sykes JE. A call for more evidence documenting human-to-dog transmission of monkeypox virus. Lancet. 2022 Sep 24;400(10357):993.Full text Abstract
387. Shepherd W, Beard PM, Brookes SM, et al. The risk of reverse zoonotic transmission to pet animals during the current global monkeypox outbreak, United Kingdom, June to mid-September 2022. Euro Surveill. 2022 Sep;27(39).Full text Abstract
388. Knight C, Andreani J, Garrett N, et al. Absence of detectable monkeypox virus DNA in 11,000 English blood donations during the 2022 outbreak. Transfusion. 2023 Apr;63(4):690-5.Full text Abstract
389. Jacobs JW, Filkins L, Booth GS, et al. The potential impact of monkeypox infection and vaccination on blood donor deferrals and the blood supply. Br J Haematol. 2022 Nov;199(3):443-6.Full text Abstract
390. Harvala H, Simmonds P. Evaluating the risk of transfusion and transplant-transmitted monkeypox infections. Transfus Med. 2022 Dec;32(6):460-6.Full text Abstract
391. US Food and Drug Administration. Information for blood establishments regarding the monkeypox virus and blood donation. Aug 2022 [internet publication].Full text
392. US Food and Drug Administration. Safety alert regarding use of fecal microbiota for transplantation and additional safety protections pertaining to monkeypox virus. August 2022 [internet publication].Full text
393. Ianiro G, Mullish BH, Iqbal TH, et al. Minimising the risk of monkeypox virus transmission during faecal microbiota transplantation: recommendations from a European expert panel. Lancet Gastroenterol Hepatol. 2022 Nov;7(11):979-80.Full text Abstract
394. Pugliese P, Arvieux C, Huleux T, et al. Proposal of the French HIV Society on the CD4 threshold below which patients living with HIV who wish to be vaccinated against monkeypox should receive a 3-dose regimen. Infect Dis Now. 2022 Nov;52(8):459-60.Full text Abstract
395. Adalja A, Inglesby T. A novel international monkeypox outbreak. Ann Intern Med. 2022 Aug;175(8):1175-6.Full text Abstract
396. Jezek Z, Marennikova SS, Mutumbo M, et al. Human monkeypox: a study of 2,510 contacts of 214 patients. J Infect Dis. 1986 Oct;154(4):551-5. Abstract
397. Payne AB, Ray LC, Kugeler KJ, et al. Incidence of monkeypox among unvaccinated persons compared with persons receiving ≥1 JYNNEOS vaccine dose: 32 U.S. jurisdictions, July 31 - September 3, 2022. MMWR Morb Mortal Wkly Rep. 2022 Oct 7;71(40):1278-82.Full text Abstract
398. Sagy YW, Zucker R, Hammerman A, et al. Real-world effectiveness of a single dose of mpox vaccine in males. Nat Med. 2023 Mar;29(3):748-52.Full text Abstract
399. Bertran M, Andrews N, Davison C, et al. Effectiveness of one dose of MVA-BN smallpox vaccine against mpox in England using the case-coverage method: an observational study. Lancet Infect Dis. 2023 Jul;23(7):828-35.Full text Abstract
400. Dalton AF, Diallo AO, Chard AN, et al. Estimated effectiveness of JYNNEOS vaccine in preventing mpox: a multijurisdictional case-control study - United States, August 19, 2022 - March 31, 2023. MMWR Morb Mortal Wkly Rep. 2023 May 19;72(20):553-8.Full text Abstract
401. Rosenberg ES, Dorabawila V, Hart-Malloy R, et al. Effectiveness of JYNNEOS vaccine against diagnosed mpox infection: New York, 2022. MMWR Morb Mortal Wkly Rep. 2023 May 19;72(20):559-63.Full text Abstract
402. Montero Morales L, Barbas Del Buey JF, Alonso García M, et al. Post-exposure vaccine effectiveness and contact management in the mpox outbreak, Madrid, Spain, May to August 2022. Euro Surveill. 2023 Jun;28(24):2200883.Full text Abstract
403. Moschetta N, Raccagni AR, Bianchi M, et al. Mpox neutralising antibodies at 6 months from mpox infection or MVA-BN vaccination: a comparative analysis. Lancet Infect Dis. 2023 Nov;23(11):e455-6.Full text
404. Hazra A, Rusie L, Hedberg T, et al. Human monkeypox virus infection in the immediate period after receiving modified vaccinia Ankara vaccine. JAMA. 2022 Nov 22;328(20):2064-7.Full text Abstract
Use of this content is subject to our disclaimer